McIver Zachariah 4
4 · Janux Therapeutics, Inc. · Filed Jan 2, 2026
Insider Transaction Report
Form 4
McIver Zachariah
Chief Medical Officer
Transactions
- Sale
Common Stock
2026-01-02$13.73/sh−2,714$37,263→ 23,286 total - Award
Common Stock
2026-01-02+29,000→ 52,286 total - Award
Stock option (right to buy)
2026-01-02+101,500→ 101,500 totalExercise: $13.65Exp: 2036-01-01→ Common Stock (101,500 underlying)
Footnotes (3)
- [F1]The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units.
- [F2]Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027.
- [F3]25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.